Global Airway Management Devices Market to Reach US$2.8 Billion by 2030

The global market for Airway Management Devices estimated at US$1.9 Billion in the year 2023, is expected to reach US$2.8 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Resuscitators, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$890.9 Million by the end of the analysis period. Growth in the Infraglottic Devices segment is estimated at 5.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$594.4 Million While China is Forecast to Grow at 6.9% CAGR

The Airway Management Devices market in the U.S. is estimated at US$594.4 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$329.3 Million by the year 2030 trailing a CAGR of 6.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.9% and 5.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.0% CAGR.

Global Airway Management Devices Market - Key Trends & Drivers Summarized

Airway management devices are essential tools in medical practice, designed to maintain or restore ventilation in patients during surgical procedures, emergencies, and intensive care. These devices include a range of products such as endotracheal tubes, laryngeal mask airways, tracheostomy tubes, and ventilators, among others. They are used to ensure that the airway remains open and that gases such as oxygen and carbon dioxide can be exchanged effectively. This field has seen significant technological advancements aimed at improving patient safety and outcomes, including the development of devices that minimize the risk of trauma or infection, and provide real-time data on patient status.

Market trends in airway management devices indicate a robust growth trajectory, influenced by several factors including rising incidences of respiratory diseases, an aging global population, and increasing healthcare expenditures. The prevalence of chronic respiratory diseases such as asthma, COPD (Chronic Obstructive Pulmonary Disease), and obstructive sleep apnea has led to a higher demand for advanced airway management solutions in both emergency and routine medical procedures. Furthermore, the COVID-19 pandemic significantly underscored the critical nature of effective airway management, leading to an unprecedented surge in the deployment of ventilators and other respiratory support technologies in hospitals around the world. The market is also witnessing a shift towards the use of disposable airway management devices to reduce the risk of cross-contamination—a trend that has been accelerated by the global pandemic.

The growth in the airway management devices market is driven by several factors, including technological innovations, regulatory policies, and demographic changes. Advanced materials and design improvements that enhance the safety and comfort of airway devices are pivotal in driving adoption rates. For example, the integration of sensors and connectivity features allows for continuous monitoring and data analytics, enhancing decision-making in critical care settings. Regulatory environments in major markets have also evolved, with stricter guidelines boosting the demand for devices that meet higher safety and efficacy standards. Additionally, the growing geriatric population, which is more prone to respiratory ailments, and the expansion of healthcare infrastructure in emerging economies are further stimulating market expansion.